5 Results for "

K562 leukaemia cells

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "K562 leukaemia cells" in MCE Product Catalog:

Cat. No.: HY-W705140A
CAS No.: 2707535-88-2
Synonyms: Hydroxymelphalan hydrochloride
Target:  

Drug Metabolite

Research Areas:  

Cancer

Monohydroxy melphalan hydrochloride (Hydroxymelphalan hydrochloride) is a degradation product of Melphalan (HY-17575), obtained through the hydrolysis of Melphalan in aqueous solutions (including cell culture media and human plasma) .
loading...
    loading...
Cat. No.: HY-N16567
CAS No.: 820975-61-9
Acrofolione A is an acetophenone dimer isolated from Acronychia pendunculata with anticancer effects. Acrofolione A induces G0/G1 phase cell cycle arrest and apoptosis in human NALM-6 pre-B cell leukaemia cells. Acrofolione A can be used for leukaemia research .
loading...
    loading...
Cat. No.: HY-144818
CAS No.: 170488-57-0
Research Areas:  

Cancer

Tubulin inhibitor 23 is a potent Tubulin inhibitor with an IC50 of 4.8 µM. Tubulin inhibitor 23 induces cell apoptosis. Tubulin inhibitor 23 shows antiangiogenic activity in a dose-dependent manner. Tubulin inhibitor 23 has the potential for the research of leukaemia .
loading...
    loading...
Cat. No.: HY-P11925
CAS No.: 934965-51-2
Research Areas:  

Cancer

CPP44 is a tumor lineage-homing cell-penetrating peptide (CPP) that selectively enters myeloid leukemia cells and liver tumor cells. The cellular internalization of CPP44 is associated with M160 (CD163L1), and it mainly enters cells via an ATP- and dynein-dependent, clathrin-independent endocytic pathway. CPP44 can be used in studies related to acute myeloid leukemia, hepatocellular carcinoma, tumor-targeted delivery, and tumor imaging .
loading...
    loading...
Cat. No.: HY-W581798
CAS No.: 17375-41-6
Research Areas:  

Metabolic Disease Cancer

Iron(II) sulfate hydrate is an iron(II) salt with oral activity, acting as an iron supplier, and is easily oxidized to iron(III) in water. Iron(II) sulfate hydrate induces apoptotic morphological changes in cancer cells, and promotes dose‑dependent iron accumulation in rats. Iron(II) sulfate hydrate can be used in studies of leukemia, breast cancer, iron deficiency, anemia, and restless legs syndrome .
loading...
    loading...